Laboratorios Sophia

What Laboratorios Sophia does

Laboratorios Sophia, S.A. de C.V., is a privately held Mexican ophthalmic pharmaceutical manufacturer headquartered in Zapopan (Guadalajara Technology Park), with founding dates ranging 1946-1949 across sources and 75+ years of operating history. The company develops, manufactures, and distributes a comprehensive ophthalmology portfolio across six therapeutic areas (dry eye, glaucoma, ocular infections, myopia, cataracts, macular degeneration), spanning prescription (RX) products such as antiglaucoma combinations, anti-inflammatories, antibiotics, immunomodulators, myopia treatments, and viscoelastics, alongside an over-the-counter consumer line of artificial tears, contact-lens solutions, and eyelid-care products. Manufacturing is anchored at a 6,520 m2 Sophia Research Center with nine production lines and advanced analytical laboratories (GC, IR, UV-VIS, UHPLC, LC-MS, rheology); formulations follow Quality by Design principles under ICH/FDA/EMA practice, supported by ISO 9001, ISO 13485, and COFEPRIS authorizations.

Sophia operates across 19 countries through staffed offices in Mexico, the United States (The Woodlands, TX), Panama, Colombia, Ecuador, Chile, Uruguay, and Argentina (via partner Brixen Labs S.A.). Revenue is generated through three streams: prescription pharmaceutical sales to ophthalmologists and institutions (sold via field reps and medical-affairs support), OTC consumer product sales through pharmacy and retail distribution across Latin America, and licensing royalties for proprietary products in territories where Sophia operates. Multiple first-in-region and first-in-world product introductions (Cyclosporine 0.1% aqueous in 2005, preservative-free Dorzolamide/Timolol/Brimonidine triple combination in 2016, Atropine 0.01% pediatric in 2023, Nanodrop with Nanotech Sophia System in 2024), a 1999 formulation patent, and a corporate CVC (Sophia Innovation Capital) for early-stage ophthalmic startups round out the operating profile. Headcount is in the 501-1000 range; revenue is not publicly disclosed.

Name

Laboratorios Sophia

Legal name

Laboratorios Sophia, S.A. de C.V.

Website

https://sophialab.com

Company type

Private

Founded year

1949

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Laboratorios Sophia is a Mexican ophthalmic pharmaceutical manufacturer founded in the late 1940s, producing prescription and OTC eye-care products across 19 Latin American countries and the United States, serving ophthalmologists, optometrists, and pharmacy consumers.

Ownership category

akta.pro rank

Product category

Ophthalmic Pharmaceuticals

NAICS

Ophthalmic Goods Manufacturing (339115), Pharmaceutical Preparation Manufacturing (325412), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Ophthalmology Specialty Pharmaceuticals (HLAIACAK)

akta.pro secondary industry

Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)

Keywords

• Ophthalmic pharmaceuticals
• Prescription eye medications
• Over-the-counter eye care
• Ocular therapeutics manufacturing
• Ophthalmic drug development

Headquarters

HQ city

Guadalajara

HQ country

Mexico

HQ region

Latin America

Offices9 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Prescription (RX) Pharmaceutical Products: Revenue from prescription ophthalmic medications including antiglaucoma, anti-inflammatory, antibiotic, antihistamine, and immunomodulatory products sold through healthcare professionals and pharmacies
2. OTC Consumer Eye Care Products: Revenue from over-the-counter products including artificial tears, eye drops for red eye/irritation, dry eye relief, and contact lens solutions sold directly to consumers through pharmacies and retail
3. License Agreements: Revenue from licensing agreements for proprietary products in territories where Sophia is present, and for expanding innovative products to new markets

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Laboratorios Sophia is a Mexican pharmaceutical manufacturer that develops, produces, and distributes a portfolio of ophthalmic products across two lines: prescription (RX) medications for conditions such as glaucoma, ocular infections, inflammation, allergies, dry eye, myopia, and cataract surgery, and over-the-counter (OTC) consumer products including artificial tears, lubricants, and contact lens solutions. Manufacturing is conducted at the company's Guadalajara facility with nine dedicated production lines and advanced analytical laboratories, with distribution reaching 19 countries in Latin America and the United States. The company also licenses proprietary formulations and operates the Sophia Innovation Capital early-stage investment fund targeting vision-related innovations.

Product overview

Laboratorios Sophia is a Mexican ophthalmic pharmaceutical company offering two main product lines: prescription (RX) products and over-the-counter (OTC) consumer products. The prescription portfolio includes treatments for glaucoma (Eliptic, Krytantek, Ponti, T-P Ofteno), anti-inflammatories (Flumetol, Trazidex, Dexafrin), antibiotics (Sophixin, Cloramfeni, Polixin), anti-allergics (Elar-B), immunomodulators (Modusik-A), myopia treatment (Alleance PF), viscoelastics (Biovisc), and combination therapies. The OTC consumer line includes artificial tears and lubricants (Lagricel PF, Humylub, Nazil, Nanodrop), contact lens solutions (Thrive, Hiprocel, Prolub), and eye care products (Hidrafy, Senseyes, Ocusoft). The company also offers prescription dry eye treatments (Meticel Ofteno, Nanodrop PF). Products are available across Latin America, the United States, and other markets.

Differentiator

Problem solved

Functional benefit

Brands

• Nazil: Red eye and irritation relief product
• Humylub Ofteno
• Lagricel PF
• Naphacel
• Manzanilla Sophia
• Meticel
• Splash Tears
• Prolub Hyfresh
• Thrive
• Hiprocel
• Hidrafy
• Senseyes HA
• Ocusoft
• Eliptic
• Sophixin
• Atro Ofteno
• Biovisc
• Modusik-A Ofteno

Products and services

• Eliptic / Eliptic PF (anti-glaucoma) Prescription anti-glaucoma ophthalmic solution (with preservative-free variant) for the treatment of elevated intraocular pressure, sold to ophthalmologists and pharmacies.
• 3-A Ofteno (triple combination Dorzolamide/Timolol/Brimonidine) Prescription triple-combination ophthalmic solution of Dorzolamide, Timolol and Brimonidine — documented regional first in preservative-free triple-combination glaucoma therapy — for ophthalmologist use.
• Alleance PF (myopia treatment) Prescription preservative-free ophthalmic solution of atropine 0.01% for pediatric myopia progression control, positioned as a Latin American first-to-market product.
• Sophixin Ofteno / Ungena (antibiotic) Prescription antibiotic ophthalmic solution and ointment for the treatment of bacterial ocular infections.
• Flumetol NF Ofteno (steroidal anti-inflammatory) Prescription steroidal anti-inflammatory ophthalmic solution for ocular inflammatory conditions.
• Biovisc (ophthalmic viscoelastic) Prescription viscoelastic ophthalmic solution used during cataract and other intraocular surgical procedures.
• Modusik-A Ofteno (immunomodulator) Prescription immunomodulatory ophthalmic solution (Cyclosporine A 0.1% in aqueous solution) for chronic dry eye and inflammatory ocular surface disease.
• Nanodrop PF (prescription artificial tear with Nanotech System) Prescription preservative-free artificial tear leveraging the Nanotech Sophia System for enhanced ocular surface delivery and dry eye relief.
• Lagricel PF (artificial tear) Over-the-counter preservative-free lubricating artificial tear in single-dose and multi-dose presentations for dry eye relief.
• Humylub Ofteno / Humylub Ofteno PF (lubricant eye drops) Over-the-counter lubricant eye drops in preserved and preservative-free formulations for dry eye relief.
• Nazil / Nazil Advanced / Nazil Ojo Irritado (red eye and irritation relief) Over-the-counter eye drops for red eye and irritation relief, including advanced and irritated-eye variants.
• Nanodrop / Nanodrop PF (OTC artificial tear with Nanotech System) Over-the-counter artificial tear leveraging the Nanotech Sophia System, with a preservative-free variant, for advanced dry eye relief.
• Thrive / Thrive Hyfresh / Thrive HyDrathan (contact lens care) Over-the-counter contact lens care solutions for cleaning, moisturizing, and hydration of contact lenses, available in multiple sizes and formulations.
• Hiprocel (contact lens care) Over-the-counter contact lens care solution for contact lens users.
• Prolub / Prolub Hyfresh / Prolub Hydrathan (eye lubricant) Over-the-counter hydrating eye lubricant in multiple sizes and formulations for dry eye relief.
• Splash Tears / Splash Red Eye (lubricant and red eye drops) Over-the-counter lubricant eye drops and red eye relief drops for consumers.
• Hidrafy (eye and eyelid contour care) Over-the-counter product for eye and eyelid contour care.
• Senseyes HA (hyaluronic acid eye contour care) Over-the-counter hyaluronic acid-based eye care product for eyelid and eye contour care.
• Ocusoft (eyelid cleansing) Over-the-counter eyelid and eye contour cleansing product.
• Manzanilla Sophia (herbal eye drop) Over-the-counter chamomile-based herbal eye drop for mild eye discomfort and irritation relief.

Quantifiable outcome

• First preservative-free triple combination of Dorzolamide, Timolol, and Brimonidine in Latin America (2017)
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Brixen Labs S.A.coreChannel Partner/ Reseller/ DistributorArgentina-based partner representing Laboratorios Sophia operations in Argentina. Located at General Fructuoso Rivera 1837, Buenos Aires, handling pharmacovigilance and local market operations.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Novartis (Ophthalmology): Novartis historically operated a major ophthalmology franchise (Lucentis, Travatan) and competes with Sophia across Rx categories in LatAm through its broader specialty pharma infrastructure.
• Allergan / AbbVie: AbbVie's Allergan Aesthetics division holds leading ophthalmology franchises (e.g., Restasis, Lumigan) and competes with Sophia in glaucoma, dry eye, and anti-infective ophthalmic categories globally and in LatAm.
• Roche (Ophthalmology / Genentech): Roche's ophthalmology franchise (Lucentis, Vabysmo for wet AMD and DME) competes with Sophia's macular degeneration-adjacent and anti-inflammatory products at the high end of the ophthalmology market.

Regional players

• Laboratorios Pisa: One of Mexico's largest domestic pharmaceutical manufacturers. While not exclusively ophthalmology-focused, Pisa's broad pharma portfolio overlaps with Sophia's prescription and OTC distribution across Mexican retail and institutional channels.
• Genomma Lab Internacional: Leading Mexican OTC consumer health company with significant LatAm distribution. It competes with Sophia's OTC portfolio (artificial tears, red eye, dry eye) across pharmacy retail in Mexico and Latin America.

Direct peers

• Bausch + Lomb: Bausch + Lomb operates one of the broadest ophthalmic portfolios spanning Rx, OTC, contact lens care, and surgical. It is a direct competitor to Sophia in preservative-free artificial tears, dry eye, and contact lens solutions across Latin America.
• Santen Pharmaceutical: Santen is a Japan-based pure-play ophthalmology company with a growing global presence. Its Rx portfolio in glaucoma, dry eye, and anti-inflammatories is directly comparable to Sophia's prescription portfolio.
• Laboratorios Alcon (Alcon México): Alcon is the global leader in eye care, with a direct Mexican/LatAm subsidiary. It directly competes with Sophia across ophthalmic pharmaceuticals, surgical devices, and contact lens care, with overlapping Rx and OTC portfolios.

Emerging players

• Apotex Inc. Canadian generics manufacturer with ophthalmic product lines. Apotex competes in commoditized ophthalmic categories where Sophia's preservative-free and combination formulations provide differentiation but where price competition pressures the broader market.
• Tarsus Pharmaceuticals: US-based emerging ophthalmology company focused on novel therapeutics (e.g., Demodex blepharitis). Represents the type of early-stage clinical innovator that Sophia Innovation Capital may invest in or compete with as it expands pipeline scope.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/Sophia_Lab_?mx=2
• Facebookfacebook.com/Sophia.Laboratorios
• LinkedInlinkedin.com/company/laboratoriossophia
• Instagraminstagram.com/laboratorios.sophia

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios Sophia